Cargando…
Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications
BACKGROUND: Generic atypical antipsychotic drugs offer health authorities opportunities for considerable savings. However, schizophrenia and bipolar disorders are complex diseases that require tailored treatments. Consequently, generally there have been limited demand-side measures by health authori...
Autores principales: | Godman, Brian, Petzold, Max, Bennett, Kathleen, Bennie, Marion, Bucsics, Anna, Finlayson, Alexander E, Martin, Andrew, Persson, Marie, Piessnegger, Jutta, Raschi, Emanuel, Simoens, Steven, Zara, Corinne, Barbui, Corrado |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073810/ https://www.ncbi.nlm.nih.gov/pubmed/24927744 http://dx.doi.org/10.1186/1741-7015-12-98 |
Ejemplares similares
-
Potential to Enhance the Prescribing of Generic Drugs in Patients with Mental Health Problems in Austria; Implications for the Future
por: Godman, Brian, et al.
Publicado: (2013) -
Different initiatives across Europe to enhance losartan utilization post generics: impact and implications
por: Moon, James C., et al.
Publicado: (2014) -
Torsadogenic Risk of Antipsychotics: Combining Adverse Event Reports with Drug Utilization Data across Europe
por: Raschi, Emanuel, et al.
Publicado: (2013) -
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications
por: Godman, Brian, et al.
Publicado: (2014) -
Discounts and rebates granted to public payers for medicines in European countries
por: Vogler, Sabine, et al.
Publicado: (2012)